Eris Lifesciences gets SEBI nod for Rs 2000 crore IPO Ruby Khatun Khatun8 May 2017 11:01 PM ISTSecurities and Exchange Board of India’s (SEBI) has granted approval for an initial public offering IPO to Ahmedabad-based pharmaceutical company Eris...
Sanofi India Q1 net profit dips 27% at Rs 60 cr Ruby Khatun Khatun8 May 2017 5:47 PM ISTNew Delhi: Drug firm Sanofi India reported a 27.36 per cent dip in standalone net profit to Rs 60 crore for the first quarter ended March 31, 2017 on...
Pfizer Q4 net profit falls 22% to Rs 68 cr Ruby Khatun Khatun8 May 2017 5:47 PM ISTNew Delhi: Drug firm Pfizer reported a 21.98 per cent dip in its standalone net profit at Rs 68.04 crore for the fourth quarter ended March 31, 2017....
USFDA issues warning to Sal Pharma Ruby Khatun Khatun8 May 2017 3:02 PM ISTNew Delhi: US health regulator USFDA has issued a warning letter to drug firm Sal Pharma for its Hyderabad facility for misbranding and deviations...
Jubilant Life Sciences to buy Triad Isotopes radio-pharmacy business Ruby Khatun Khatun7 May 2017 9:50 AM ISTNew Delhi: Jubilant Life Sciences' subsidiary Jubilant Pharma will acquire the radio-pharmacy business of US-based Triad Isotopes for an undisclosed...
Hetero gets DCGI nod for generic chronic hepatitis C drug Ruby Khatun Khatun7 May 2017 9:49 AM ISTNew Delhi: Drug firm Hetero said it has received nod from the regulator DCGI for its generic Sofosbuvir and Velpatasvir combination tablets used for...
Strides Shasun's plant completes successful USFDA inspection Ruby Khatun Khatun7 May 2017 9:35 AM ISTNew Delhi: Drug firm Strides Shasun said the US health regulator has not made any observations after inspection of its manufacturing facility in...
GST Jitters- Chemists not stocking Drugs, Abbott promises compensations Ruby Khatun Khatun6 May 2017 3:24 PM ISTMumbai: In the wake of the goods and services tax (GST) regime introduction with effect from July 1, 2017 chemists are reported to have stopped...
Johnson & Johnson ordered to pay 110 million dollar in U.S. talc-powder trial Ruby Khatun Khatun6 May 2017 2:04 PM ISTJohnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer...
Novartis exercises option with Conatus for NASH product Ruby Khatun Khatun6 May 2017 2:04 PM ISTNovartis is exercising its option with Conatus Pharmaceuticals for an exclusive license for the global development and commercialization of emricasan...
Tata Capital Healthcare Fund advances 4 million dollar to Brinton Pharma Ruby Khatun Khatun5 May 2017 12:34 PM ISTTata Capital Healthcare Fund has advanced $4 million (approx Rs 25.6 crore) to Brinton Pharmaceuticals, one of the fastest growing pharmaceutical...
Novartis, Roche back French gene therapy start-up Vivet Ruby Khatun Khatun5 May 2017 12:25 PM ISTFrench gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with...
